4.5 Article

Evaluation of chromogenic meticillin-resistant Staphylococcus aureus media: sensitivity versus turnaround time

Journal

JOURNAL OF HOSPITAL INFECTION
Volume 81, Issue 1, Pages 20-24

Publisher

W B SAUNDERS CO LTD
DOI: 10.1016/j.jhin.2012.02.003

Keywords

Culture; Incubation length; Meticillin-resistant; Staphylococcus aureus; Screening

Ask authors/readers for more resources

Background: Chromogenic media offer the potential for improved detection of meticillin-resistant Staphylococcus aureus (MRSA). Incubation times in a clinical setting vary, generally between 16 and 48 h. Aim: To investigate the effects of incubation time on the performance of commercial chromogenic MRSA media. Methods: We initially compared the early recovery of MRSA isolates from routine screening swabs following 16-23 h to that after 22-24 h of incubation using ChromID MRSA (bioMerieux). We also compared ChromID MRSA, ChromID MRSA V2 (bioMerieux), Brilliance MRSA 2 Agar (Oxoid) and Colorex MRSA (E&O Laboratories Ltd) as selective media for 6035 MRSA screening swabs. Findings: Only 303 of 623 (48.6%) MRSA isolates detected by this medium after 48 h were recovered after 16-23 h compared with 726 of 1018 (71.3%) isolates after 22-24 h. Following implementation of the 22-24 h incubation period, 50 (4.4%) isolates exhibiting a positive chromogenic reaction gave conflicting coagulase latex and DNase results. In 88% of these cases, DNase gave the correct result of non-MRSA. ChromID MRSA demonstrated the highest sensitivity overall at 93.2%, followed by Colorex MRSA Agar (87.1%), ChromID V2 (83.7%) and Brilliance Agar (78.2%). All media exhibited specificities of >99.7%. Conclusion: Early detection of MRSA using ChromID MRSA is best achieved after incubation for 22-24 h. Latex agglutination coagulase tests alone should not be relied upon for identification of MRSA isolates from this medium. Although ChromID MRSA was deemed the superior medium in terms of MRSA recovery, the disadvantages of increased turnaround time (48 vs 24 h) must be considered. (C) 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available